Pfizer'sPFEstock rose almost 5% on Tuesday after it announced an encouraging guidance for 2025. Pfizer projected total revenues between $61.0 billion and $64.0 billion. The Zacks Consensus Estimate for the metric is pegged at $62.86 billion. Adjusted earnings are expected in the range of $2.80 ...
Eli Lilly (LLY) Stockpiles Weight Loss Pill Ahead of Regulatory ApprovalFebruary 20, 2025TipRanks Starboard Value buys Pfizer, exits Humana in Q4February 14, 2025TipRanks Senate votes to confirm Robert Kennedy as head of HHSFebruary 13, 2025TipRanksRelated...
Pfizer stock is now trading below its 50-day moving average and 200-day line. (Related: Keep tabs on chart patterns by visiting IBD's MarketSurge.) Pfizer stock has an IBD Digital Composite Rating of 74 out of a best-possible 99. The CR is a measure of a stock's fundamental and tec...
Pfizer: Undervalued Safe Haven In Risk-Off Market 2 daysago |seekingalpha.com Pfizer's COVID-19 Shot Partner BioNTech Reports Q4 Profit, But 2025 Guidance Falls Short On Expectations 3 daysago |benzinga.com Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold?
Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate. Feb. 4, 2025 at 12:58 p.m. ET by James Rogers Pfizer Shares Rise on Better-Than-Expected 4Q Feb. 4, 2025 at 9:43 a.m. ET Other News Press Releases GILD Stock ...
A day earlier, the pharmaceutical giant's stock had closed 6% higher after itsquarterly resultstopped analyst estimates and it hiked itsfull-year outlook. It was afar cry from the year prior, when Pfizer's shares plunged more than 40%, making it one of the worst-performing large pharmaceutica...
Pfizer’s stock has declined 8.4% in the past year compared with a decrease of 1.9% for theindustry. PFE Stock Underperforms Industry Image Source: Zacks Investment Research From a valuation standpoint, Pfizer appears attractive relative to the industry and is trading below its 5-year mean. Goi...
PFE Stock 12 Month Forecast $31.56 ▲(24.99% Upside) Based on19Wall Street analysts offering 12 month price targets forPfizerin the last3 months. The average price target is$31.56with a high forecast of$45.00and a low forecast of$25.00. The average price target represents a24.99%change from...
Pfizer, Inc. Stock Equities PFE US7170811035 Pharmaceuticals Real-time EstimateCboe BZX 03:01:35 2025-03-06 pm EST5-day change1st Jan Change 26.37USD+1.64% +1.09%-0.55% 02:29pmModerna Wins Patent Ruling Against Pfizer, BioNTech in German CourtMT...
Pfizer (Pharmaceuticals) Stock Performance As of 14-Mar-2025, Pfizer (Pharmaceuticals)’s stock price is $25.72. Its current market cap is $146B with 5.67B shares. (As of Friday Closing) Stock PricePrevious Close52 wk RangeMarket CapSharesAverage VolumeEPS ...